Generic filters
Filter by content type
Taxonomy terms

BTTX – Better Therapeutics Inc


Subscribe for full access

Unlock Industry-grade Shariah Compliance for US, UK, Canada, Germany, GCC, Europe and India. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.

Get started from just $1/month


Recommendation Rating







1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Analysts’ Price Targets

Mean 17

Low: 15

High: 21

Total Analysts: 3

Company Profile

Better Therapeutics, Inc. is a prescription digital therapeutics (PDT) company. The Company is engaged in developing a novel form of cognitive-behavioral therapy to address the root causes of cardiometabolic diseases. The Company’s Nutritional Cognitive Behavioral Therapy (Nutritional CBT) is a novel form of behavioral therapy for patients with type 2 diabetes and other cardiometabolic diseases. It targets the cognitive structures, behavioral routines, emotional patterns, and coping skills that underlie culturally specific eating behaviors. Its clinical development pipeline includes BT-001, BT-002, BT-003, and BT-004. The BT-001 is an investigational PDT platform that is designed to use digitally delivered Nutritional CBT to treat type 2 diabetes. The Company’s platform consists of three integrated components, behavioral therapy, treatment plans, and personalization. Its behavioral therapy consists of lessons, skill-building modules, and a mechanism for goal setting.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan